MUSC and Bristol-Myers Squibb Announce Translational Research Collaboration
The Medical University of South Carolina and Bristol-Myers Squibb Company (NYSE: BMY) today announced that they have entered into a translational research collaboration focused on fibrotic diseases, including scleroderma, renal fibrosis and idiopathic pulmonary fibrosis. The agreement includes studies designed to improve the mechanistic understanding of fibrosis,…